US10905119B2 - Anti-microbial compositions comprising quaternary organosilane compounds - Google Patents
Anti-microbial compositions comprising quaternary organosilane compounds Download PDFInfo
- Publication number
- US10905119B2 US10905119B2 US16/098,504 US201716098504A US10905119B2 US 10905119 B2 US10905119 B2 US 10905119B2 US 201716098504 A US201716098504 A US 201716098504A US 10905119 B2 US10905119 B2 US 10905119B2
- Authority
- US
- United States
- Prior art keywords
- formula
- quaternary ammonium
- radicals
- composition
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 27
- 239000004599 antimicrobial Substances 0.000 title claims abstract description 19
- -1 organosilane compounds Chemical class 0.000 title claims description 6
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims abstract description 99
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 30
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 30
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- 244000005700 microbiome Species 0.000 claims abstract description 9
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 7
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims abstract description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 6
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 6
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims abstract description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 6
- 239000010452 phosphate Substances 0.000 claims abstract description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 51
- 150000001875 compounds Chemical class 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000006260 foam Substances 0.000 claims description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 3
- 125000005103 alkyl silyl group Chemical group 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- WSFMFXQNYPNYGG-UHFFFAOYSA-M dimethyl-octadecyl-(3-trimethoxysilylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC WSFMFXQNYPNYGG-UHFFFAOYSA-M 0.000 claims description 3
- 239000003595 mist Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000003897 fog Substances 0.000 claims description 2
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 60
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 26
- 229910052710 silicon Inorganic materials 0.000 description 26
- 239000010703 silicon Substances 0.000 description 25
- 241000700605 Viruses Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 244000052769 pathogen Species 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000191936 Micrococcus sp. Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005923 long-lasting effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 241001263478 Norovirus Species 0.000 description 2
- 241000588912 Pantoea agglomerans Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- LTIPUQSMGRSZOQ-UHFFFAOYSA-N [C].[C].[O] Chemical compound [C].[C].[O] LTIPUQSMGRSZOQ-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical group 0.000 description 2
- 150000003868 ammonium compounds Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003253 viricidal effect Effects 0.000 description 2
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
- 241001438630 Acremonium cereale Species 0.000 description 1
- 241000223602 Alternaria alternata Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241000588917 Citrobacter koseri Species 0.000 description 1
- 241001149955 Cladosporium cladosporioides Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000305109 Curvularia australiensis Species 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001480000 Microsporum audouinii Species 0.000 description 1
- 241001363490 Monilia Species 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000331871 Ochroconis humicola Species 0.000 description 1
- 241001434386 Paraphoma fimeti Species 0.000 description 1
- 241001574249 Pithomyces chartarum Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010035742 Pneumonitis Diseases 0.000 description 1
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589538 Pseudomonas fragi Species 0.000 description 1
- 241000702263 Reovirus sp. Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607132 Salmonella enterica subsp. enterica serovar Gallinarum Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- APTVNWGLSRAOFJ-UHFFFAOYSA-M dimethyl(dioctyl)azanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCCCCCC APTVNWGLSRAOFJ-UHFFFAOYSA-M 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- CSJDCSCTVDEHRN-UHFFFAOYSA-N methane;molecular oxygen Chemical group C.O=O CSJDCSCTVDEHRN-UHFFFAOYSA-N 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- 229940112041 peripherally acting muscle relaxants other quaternary ammonium compound in atc Drugs 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
Definitions
- the present invention relates to an anti-microbial composition, a method of making an anti-microbial composition and a method of reducing the number of microbes on a surface using an anti-microbial composition.
- an antimicrobial composition comprising at least two quaternary ammonium compounds selected from:
- A is a member selected from the group consisting of alkoxy radicals of 1 to 10 carbon atoms, alkylether alkoxy radicals of 2 to 10 carbon atoms, and alkyl radicals with 1 to 10 carbon atoms; and/or
- the composition comprises two quaternary ammonium compounds of formula (i) and no quaternary ammonium compounds of formula (ii).
- the composition comprises two quaternary ammonium compounds of formula (i) and one quaternary ammonium compound of formula (ii).
- an R 1 group of one of the quaternary ammonium compounds is different from the R 1 group or groups of the other quaternary ammonium compound or compounds.
- At least one R 1 group has 18 carbon atoms.
- one of the quaternary ammonium compounds is 3-(trimethoxysilyl) propyl dimethyl octadecyl ammonium chloride.
- one of the quaternary ammonium compounds is alkyl silyl dimethyl benzyl ammonium chloride.
- one of the quaternary ammonium compounds is dioctyl silyl dimethyl ammonium bromide.
- the composition comprises water and/or ethanol.
- the composition comprises the quaternary ammonium compounds in a concentration of from about 0.1 to about 5% by volume, preferably about 0.5 to about 2% by volume.
- an anti-microbial composition as defined in any of the preceding paragraphs, the method comprising admixing the at least two quaternary ammonium compounds.
- a method of reducing the number of micro-organisms on a surface comprising contacting said surface with an antimicrobial composition comprising at least two quaternary ammonium compounds selected from:
- A is a member selected from the group consisting of alkoxy radicals of 1 to 10 carbon atoms, alkylether alkoxy radicals of 2 to 10 carbon atoms, and alkyl radicals with 1 to 10 carbon atoms;
- composition is as defined in any of the above paragraphs.
- the surface is skin.
- the surface is an inanimate surface.
- the anti-microbial composition is used as a spray, foam, mist, fog or wipes.
- Quaternary ammonium compounds are widely used as disinfectants. These compounds can remain on surfaces to give a persistent effect, allowing them to remain active on surfaces after cleaning.
- the quaternary compounds are organically substituted ammonium compounds having four substituents (e.g. alkyl or heterocyclic radicals of a given size or chain length), and an associated anion, such as a halide, sulfate, or similar moiety. These compounds exhibit antimicrobial characteristics.
- substituents e.g. alkyl or heterocyclic radicals of a given size or chain length
- anion such as a halide, sulfate, or similar moiety.
- Some known quaternary ammonium compounds used in healthcare are alkyl dimethyl benzyl ammonium chloride, didecyl dimethyl ammonium chloride, dialkyl dimethyl ammonium chloride, didecyl dimethyl ammonium bromide and dioctyl dimethyl ammonium bromide.
- the bactericidal action of the quaternary compounds has been attributed to the inactivation of energy-producing enzymes, denaturation of essential cell proteins, and disruption of the cell membrane.
- the quaternary compounds used as hospital disinfectants are generally fungicidal, bactericidal, and virucidal against lipophilic (enveloped) viruses. More recent quaternary compounds have been found to have improved efficacy, for example with activity against spores, Mycobacterium tuberculosis , and virucidal against hydrophilic (nonenveloped) viruses.
- compositions comprising these antimicrobial compounds are used in ordinary environmental sanitation of surfaces, especially hard surfaces, such as floors, furniture, and walls.
- Some specific quaternary ammonium compounds are also appropriate to use for disinfecting medical equipment that contacts intact skin (e.g., blood pressure cuffs), and food preparation surfaces.
- Tests were performed to verify the efficacy of anti-microbial compositions in accordance with the invention.
- the tests were performed on sample patches of worktop material (2 cm 2 surface) which were contaminated with a measured amount of a microbe (10,000 CFU Staph. aureus ).
- the samples were then subjected to treatment with compositions (compositions 1, 2 and 3 detailed below) followed by testing for the level of microbes with daily cleaning.
- compositions comprising a single silicon-containing quaternary ammonium compound, two silicon-containing quaternary ammonium compounds and three silicon-containing quaternary ammonium compounds.
- the compounds were used as solutions in a water/ethanol mixture.
- the concentration of each composition was 1% by volume of the quaternary ammonium compound(s) in 17% ethanol/82% sterile water.
- Composition 1 contained 3-(trimethoxysilyl) propyl dimethyl octadecyl ammonium chloride.
- Composition 2 additionally contained alkyl silyl dimethyl benzyl ammonium chloride.
- Composition 3 additionally contained dioctyl silyl dimethyl ammonium bromide.
- Composition 1 contained a single quaternary ammonium compound.
- Composition 2 contained two quaternary ammonium compounds.
- Composition 3 contained three quaternary ammonium compounds. All of the quaternary ammonium compounds used in the tests contained silicon.
- compositions of the invention having improved anti-microbial activity.
- the anti-microbial activity is long lived as the composition persists on the surface for a relatively long period of time.
- the composition comprises at least two quaternary ammonium compounds as defined in the claims. At least two of the quaternary ammonium compounds are silicon-containing quaternary ammonium compounds.
- the quaternary ammonium compounds are defined below, forming an antimicrobial composition comprising at least two quaternary ammonium compounds selected from:
- the compounds of formula (i) are silicon-containing ammonium quaternary compounds.
- the compounds of formula (ii) are quaternary ammonium compounds that do not contain silicon.
- the focus of the invention is based on compositions that contain more than one silicon-containing quaternary ammonium compound. The applicants have found that there are several advantages to such compositions over prior art compositions.
- a combination of silicon-containing quaternary ammonium compounds provides more effective anti-microbial action, both in terms of immediate effect and also long lasting (persistent) effect.
- the use of more than one silicon-containing quaternary ammonium compound allows for more effective cleaning.
- the compositions of the invention can also contain further components. These further components can include quaternary ammonium compounds that do not contain silicon, and/or other components, such as surfactants.
- compositions contain quaternary compounds in which, independently, A is a member selected from the group consisting of alkoxy radicals of 1 to 10 carbon atoms, alkylether alkoxy radicals of 2 to 10 carbon atoms, and alkyl radicals with 1 to 10 carbon atoms; and/or R is a divalent hydrocarbon radical with 1 to 10 carbon atoms; and/or each R 1 is independently a member selected from the group consisting of benzyl, alkyl radicals with 1 to 30 carbon atoms, alkyl ether hydrocarbon radicals of 2 to 30 carbon atoms, hydroxyl-containing alkyl radicals of 1 to 30 carbon atoms, and nitrogen-containing hydrocarbon radicals of 1 to 30 carbon atoms.
- compositions contain at least three quaternary ammonium compounds, of which at least two are silicon-containing quaternary compounds as defined in formula (i) above.
- compositions of the invention include compositions comprising two silicon-containing quaternary ammonium compounds of formula (i) and no quaternary ammonium compounds of formula (ii); two quaternary ammonium compounds of formula (i) and one quaternary ammonium compound of formula (ii); two silicon-containing quaternary ammonium compounds of formula (i) and two silicon-containing quaternary ammonium compounds of formula (ii); two silicon-containing quaternary ammonium compounds of formula (i) and three quaternary ammonium compounds of formula (ii); three silicon-containing quaternary ammonium compounds of formula (i) and no quaternary ammonium compounds of formula (ii); three silicon-containing quaternary ammonium compounds of formula (i) and one quaternary ammonium compound of formula (ii); three silicon-containing quaternary ammonium compounds of formula (i) and one quaternary ammonium compound of formula (ii); three silicon-containing quaternary ammonium compounds of
- a composition comprising a mixture of quaternary ammonium compounds of the invention (containing at least two silicon-containing ammonium quaternary compounds) is particularly effective at reducing and eliminating the number of micro-organisms on a surface.
- the ammonium compounds Preferably have a mixture of long chain groups.
- At least two of the quaternary ammonium compounds in the composition are silicon containing quaternary ammonium compound (i.e. a compound of formula (i) as set out above).
- micro-organism refers to a pathogen such as a virus or bacteria.
- the micro-organism is a bacteria.
- pathogens A non-exhaustive list of pathogens is given below:
- Salmonella typhosa Salmonella typhosa
- HIV-1 HIV-1 (AIDS)
- compositions of the invention generally contain the quaternary ammonium compounds in a solvent.
- the solvent is preferably aqueous, and more preferably a mixture of water and alcohol, preferably ethanol.
- the composition may contain methanol, for example as a stabiliser.
- pathogen as used herein also includes gram positive and gram negative bacteria, viruses and fungi, including yeasts and moulds.
- alkyl refers to a straight chain or branched saturated hydrocarbon.
- alkylether alkoxy refers to an alkyl ether moiety containing carbon-oxygen-carbon bonds and having a terminal oxygen atom bonded to the silicon atom.
- alkyl ether refers to an alkyl group as defined above containing within the carbon chain a carbon-oxygen-carbon linkage. Polyethers are also included in this definition as being alkyl groups containing more than one carbon-oxygen-carbon linkage.
- alkoxy refers to alkyl groups defined as above which have a terminal carbon-oxygen linkage. “Lower” used herein in reference to alkyl, alkoxy and alcohols, indicates species and compounds having 1 to 4 carbons.
- antimicrobial as used herein is used in reference to the ability of the compound composition or article to eliminate, remove, inactivate, kill or reduce microorganisms such as bacteria, viruses, fungi, moulds, yeasts and spores.
- antimicrobial as used herein to imply reduction and elimination of the growth and formation of microorganisms such as described above.
- compositions of the invention can be used in many different applications in order to reduce and/or eliminate the number of pathogens.
- they can be used on inanimate surfaces. They can be used in healthcare environments, in the home and other situations in order to disinfect surfaces. Such applications include the food industry, water treatment and hospitals.
- the Applicants have found that the application of the composition to a surface reduces substantially the number of pathogens within a very short period of time.
- the composition produces a long-lasting pathogenic effect from the application of the composition to a surface.
- the quaternary ammonium compounds of the compositions of the invention persist on the surface even if they are subjected to normal use, for a period of time.
- the compositions have been found to be effective against viruses, and against norovirus in particular.
- the composition of the invention is a liquid.
- the composition could be used as a spray, to be sprayed onto surfaces. The surfaces are then either be left for the composition to dry, or the composition may be wiped with a clean cloth or other implement and then left to dry.
- the composition of the invention can also be provided as a foam, to be applied to a surface. The composition could be released from a container which forms the foam, for example by entraining air.
- the composition may optionally contain components to aid in the formation of the foam.
- the composition of the invention may also be used in the form of a wetted wipe. So, a wipe impregnated with the composition may be used to wipe a surface. Another way of applying the composition is through the generation of a fog. In other words, small liquid particles of the composition of the invention may be formed to generate a mist or fog, which can then contact surfaces to be disinfected.
- compositions of the invention become more effective some time after being applied to a surface and left to dry. Without being bound by theory, the Applicants believe that at least some of the components of the composition may become bonded to the surface, giving a long lasting persistent anti-microbial effect. This could be, in the case of a silicon-containing quaternary ammonium compound, hydrolysis in the formation of a bond with the material of the surface being disinfected.
- the compounds of the invention contain at least two different quaternary ammonium compounds, of which at least two are silicon-containing quaternary ammonium compounds as defined in formula (i) in the claims.
- the composition contains at least two quaternary ammonium compounds, each having at least one pendant group having at least eight carbon atoms. More preferably, each of the at least two quaternary ammonium compounds has such an organic moiety which has a different chain length from the other groups in the other quaternary ammonium compounds in the composition.
- the quaternary ammonium compounds used in the invention be provided in an aqueous solvent.
- the solvent could be essentially water, it is preferred that the solvent comprises water and an alcohol, such as ethanol. This reduces the drying time of the composition when applied to a surface. If desired, the composition can contain other optional components.
- compositions of the invention can be made, for example, by admixing the at least two quaternary ammonium compounds with a solvent.
- the compositions may be provided in a concentration which is ready to use, or may be provided in the concentrated form, ready for dilution to a more appropriate concentration when needed.
- compositions of the invention could be used to disinfect a surface of the living body, for example the skin.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
-
- (i) a quaternary ammonium compound having the formula:
A4-nSi(R—NHaR1 bZ)n - and
- (ii) a quaternary ammonium compound having the formula:
NHcR1 dZ - wherein in each of the at least two quaternary ammonium compounds A, R, R1, a, Z and n are independently selected, and:
- A is a member selected from the group consisting of alkoxy radicals, alkylether alkoxy radicals, and alkyl radicals;
- R is a divalent hydrocarbon radical;
- each R1 is independently a member selected from the group consisting of benzyl, alkyl radicals, alkyl ether hydrocarbon radicals, hydroxyl-containing alkyl radicals, and nitrogen-containing hydrocarbon radicals;
- Z is a member selected from the group consisting of chloride, bromide, iodide, tosylate, hydroxide, sulfate and phosphate;
- a is 0, 1 or 2, b is 1, 2 or 3, and the sum of a and b is 3;
- c is 0, 1, 2 or 3, d is 1, 2, 3 or 4, and the sum of c and d is 4; and
- n is 1, 2 or 3; and
- wherein the composition comprises at least two quaternary ammonium compounds of formula (i).
- (i) a quaternary ammonium compound having the formula:
-
- R is a divalent hydrocarbon radical with 1 to 10 carbon atoms; and/or
- each R1 is independently a member selected from the group consisting of benzyl, alkyl radicals with 1 to 30 carbon atoms, alkyl ether hydrocarbon radicals of 2 to 30 carbon atoms, hydroxyl-containing alkyl radicals of 1 to 30 carbon atoms, and nitrogen-containing hydrocarbon radicals of 1 to 30 carbon atoms.
-
- (i) a quaternary ammonium compound having the formula:
A4-nSi(R—NHaR1 bZ)n - and
- (ii) a quaternary ammonium compound having the formula:
NHcR1 dZ - wherein in each of the at least two quaternary ammonium compounds A, R, R1, a, Z and n are independently selected, and:
- A is a member selected from the group consisting of alkoxy radicals of 1 to 10 carbon atoms, alkylether alkoxy radicals of 2 to 10 carbon atoms, and alkyl radicals with 1 to 10 carbon atoms;
- R is a divalent hydrocarbon radical with 1 to 10 carbon atoms;
- each R1 is independently a member selected from the group consisting of benzyl, alkyl radicals with 1 to 30 carbon atoms, alkyl ether hydrocarbon radicals of 2 to 30 carbon atoms, hydroxyl-containing alkyl radicals of 1 to 30 carbon atoms, and nitrogen-containing hydrocarbon radicals of 1 to 30 carbon atoms;
- Z is a member selected from the group consisting of chloride, bromide, iodide, tosylate, hydroxide, sulfate and phosphate;
- a is 0, 1 or 2, b is 1, 2 or 3, and the sum of a and b is 3;
- c is 0, 1, 2 or 3, d is 1, 2, 3 or 4, and the sum of c and d is 4; and
- n is 1, 2 or 3; and
- wherein the composition comprises at least two quaternary ammonium compounds of formula (i).
- (i) a quaternary ammonium compound having the formula:
-
- R is a divalent hydrocarbon radical with 1 to 10 carbon atoms; and
- each R1 is independently a member selected from the group consisting of benzyl, alkyl radicals with 1 to 30 carbon atoms, alkyl ether hydrocarbon radicals of 2 to 30 carbon atoms, hydroxyl-containing alkyl radicals of 1 to 30 carbon atoms, and nitrogen-containing hydrocarbon radicals of 1 to 30 carbon atoms;
| Day of treatment | ||
| 7 | 14 | 21 | 28 | 3 | ||
| Results in CFU per cm2 | days | days | days | days | months | |
| 3 × 2 cm2 patches of work | ||||||
| top contaminated with | ||||||
| 10,000 CFU staph | ||||||
| aureus and isolated tests | ||||||
| performed prior to | ||||||
| vigorous daily cleaning | ||||||
| Before treatment | 9889 | |||||
| Compound 1 (single Si | 3 | 3 | 4 | 9 | 167 | 2889 |
| Quat) | ||||||
| Before treatment | 9878 | |||||
| Compound 2 (2 × Si | 0 | 0 | 3 | 3 | 87 | 683 |
| Quats) | ||||||
| Before treatment | 9920 | |||||
| Compound 3 (3 × Si | 0 | 0 | 0 | 0 | 0 | 4 |
| Quats) | ||||||
-
- (i) a quaternary ammonium compound having the formula:
A4-nSi(R—NHaR1 bZ)n - and
- (ii) a quaternary ammonium compound having the formula:
NHcR1 dZ - wherein in each of the at least three quaternary ammonium compounds A, R, R1, a, Z and n are independently selected, and:
- A is a member selected from the group consisting of alkoxy radicals of 1 to 10 carbon atoms, alkylether alkoxy radicals of 2 to 10 carbon atoms, and alkyl radicals with 1 to 10 carbon atoms;
- R is a divalent hydrocarbon radical with 1 to 10 carbon atoms;
- each R1 is independently a member selected from the group consisting of benzyl, alkyl radicals with 1 to 30 carbon atoms, alkyl ether hydrocarbon radicals of 2 to 30 carbon atoms, hydroxyl-containing alkyl radicals of 1 to 30 carbon atoms, and nitrogen-containing hydrocarbon radicals of 1 to 30 carbon atoms;
- Z is a member selected from the group consisting of chloride, bromide, iodide, tosylate, hydroxide, sulfate and phosphate;
- a is 0, 1 or 2, b is 1, 2 or 3, and the sum of a and b is 3;
- c is 0, 1, 2 or 3, d is 1, 2, 3 or 4, and the sum of c and d is 4; and
- n is 1, 2 or 3; and
- wherein the composition comprises at least two quaternary ammonium compounds of formula (i).
- (i) a quaternary ammonium compound having the formula:
Claims (14)
A4-nSi(R—NHaR1 bZ)n
NHcR1 dZ
A4-nSi(R—NHaR1 bZ)n
NHcR1 dZ
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1607699.4A GB201607699D0 (en) | 2016-05-03 | 2016-05-03 | Anti-microbial compositions |
| GB1607699.4 | 2016-05-03 | ||
| PCT/EP2017/059676 WO2017190972A1 (en) | 2016-05-03 | 2017-04-24 | Anti-microbial compositions comprising quaternary organosilane compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2017/059676 A-371-Of-International WO2017190972A1 (en) | 2016-05-03 | 2017-04-24 | Anti-microbial compositions comprising quaternary organosilane compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/141,511 Continuation US11553714B2 (en) | 2016-05-03 | 2021-01-05 | Anti-microbial compositions comprising quaternary organosilane compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20190141997A1 US20190141997A1 (en) | 2019-05-16 |
| US10905119B2 true US10905119B2 (en) | 2021-02-02 |
Family
ID=56234294
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/098,504 Active US10905119B2 (en) | 2016-05-03 | 2017-04-24 | Anti-microbial compositions comprising quaternary organosilane compounds |
| US17/141,511 Active US11553714B2 (en) | 2016-05-03 | 2021-01-05 | Anti-microbial compositions comprising quaternary organosilane compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/141,511 Active US11553714B2 (en) | 2016-05-03 | 2021-01-05 | Anti-microbial compositions comprising quaternary organosilane compounds |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10905119B2 (en) |
| EP (1) | EP3451832A1 (en) |
| CN (1) | CN109152365A (en) |
| AU (1) | AU2017259630B2 (en) |
| CA (1) | CA3023037A1 (en) |
| GB (1) | GB201607699D0 (en) |
| SA (1) | SA518400331B1 (en) |
| SG (1) | SG11201809161UA (en) |
| WO (1) | WO2017190972A1 (en) |
| ZA (1) | ZA201806923B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11553714B2 (en) * | 2016-05-03 | 2023-01-17 | Q Surgical Technologies Ltd. | Anti-microbial compositions comprising quaternary organosilane compounds |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210137120A1 (en) * | 2019-11-11 | 2021-05-13 | Parasol Medical, Llc | Sanitizing and antimicrobial solution with silane quaternary ammonium with hypochlorous acid |
| US20220295788A1 (en) * | 2020-04-30 | 2022-09-22 | Joseph H. James | High performance antimicrobial composition |
| US20250275536A1 (en) * | 2022-05-03 | 2025-09-04 | Patrick Kamer | Antimicrobial Composition |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3418355A (en) * | 1964-10-16 | 1968-12-24 | Hoffmann La Roche | Didecyl quaternary ammonium compounds |
| WO2000054587A1 (en) | 1999-03-16 | 2000-09-21 | Coating Systems Laboratories, Inc. | Antimicrobial skin preparations containing organosilane quaternaries |
| WO2000072850A1 (en) | 1999-05-28 | 2000-12-07 | Coating Systems Laboratories, Inc. | Foot care compositions containing quaternary ammonium organosilanes |
| US6994890B2 (en) * | 2003-10-31 | 2006-02-07 | Resource Development L.L.C. | Cleaning and multifunctional coating composition containing an organosilane quaternary compound and hydrogen peroxide |
| WO2006086271A2 (en) | 2005-02-07 | 2006-08-17 | Jacques Elfersy | Methods and compositions for biocidal treatments |
| US20070065475A1 (en) | 2005-02-07 | 2007-03-22 | Jacques Elfersy | Methods and compositions for antimicrobial surfaces |
| US20070163964A1 (en) | 2005-11-07 | 2007-07-19 | Williamson J K | Methods and compositions for filtration media |
| US20070237901A1 (en) | 2006-03-02 | 2007-10-11 | Moses Timothy C | Water-Stabilized Antimicrobial Organosilane Products, Compositions, and Methods for Using the Same |
| WO2009030640A1 (en) | 2007-09-06 | 2009-03-12 | Vitec Speciality Chemicals Limited | Methods for diluting water-stabilized antimicrobial organosilane compositions |
| US20110293542A1 (en) | 2008-12-25 | 2011-12-01 | Hiroki Nikawa | Antibacterial agent composition and antiviral agent composition comprising silicon-containing compound; antibacterializing method, cleaning/mouth rinsing method; method for fixing antibacterial agent and antiviral agent |
| US20120125226A1 (en) * | 2010-05-07 | 2012-05-24 | Resource Development L.L.C. | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use |
| JP2013071893A (en) | 2011-09-27 | 2013-04-22 | Lixil Corp | Antiviral antibacterial coating agent |
| CN104798809A (en) | 2015-03-12 | 2015-07-29 | 江西领行药业有限公司 | Organosilicon quaternary ammonium long-acting antibacterial product and preparation method thereof |
| WO2016164545A1 (en) | 2015-04-07 | 2016-10-13 | Indusco, Inc. | Antimicrobial articles and compounds therefor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201607699D0 (en) * | 2016-05-03 | 2016-06-15 | Surgical Ltd Q | Anti-microbial compositions |
-
2016
- 2016-05-03 GB GBGB1607699.4A patent/GB201607699D0/en not_active Ceased
-
2017
- 2017-04-24 CN CN201780026660.9A patent/CN109152365A/en active Pending
- 2017-04-24 US US16/098,504 patent/US10905119B2/en active Active
- 2017-04-24 EP EP17718932.1A patent/EP3451832A1/en not_active Withdrawn
- 2017-04-24 CA CA3023037A patent/CA3023037A1/en active Pending
- 2017-04-24 SG SG11201809161UA patent/SG11201809161UA/en unknown
- 2017-04-24 WO PCT/EP2017/059676 patent/WO2017190972A1/en not_active Ceased
- 2017-04-24 AU AU2017259630A patent/AU2017259630B2/en not_active Ceased
-
2018
- 2018-10-17 ZA ZA2018/06923A patent/ZA201806923B/en unknown
- 2018-10-29 SA SA518400331A patent/SA518400331B1/en unknown
-
2021
- 2021-01-05 US US17/141,511 patent/US11553714B2/en active Active
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3418355A (en) * | 1964-10-16 | 1968-12-24 | Hoffmann La Roche | Didecyl quaternary ammonium compounds |
| WO2000054587A1 (en) | 1999-03-16 | 2000-09-21 | Coating Systems Laboratories, Inc. | Antimicrobial skin preparations containing organosilane quaternaries |
| WO2000072850A1 (en) | 1999-05-28 | 2000-12-07 | Coating Systems Laboratories, Inc. | Foot care compositions containing quaternary ammonium organosilanes |
| US6994890B2 (en) * | 2003-10-31 | 2006-02-07 | Resource Development L.L.C. | Cleaning and multifunctional coating composition containing an organosilane quaternary compound and hydrogen peroxide |
| WO2006086271A2 (en) | 2005-02-07 | 2006-08-17 | Jacques Elfersy | Methods and compositions for biocidal treatments |
| US20060193816A1 (en) | 2005-02-07 | 2006-08-31 | Jacques Elfersy | Methods and compositions for biocidal treatments |
| US20070065475A1 (en) | 2005-02-07 | 2007-03-22 | Jacques Elfersy | Methods and compositions for antimicrobial surfaces |
| US20070163964A1 (en) | 2005-11-07 | 2007-07-19 | Williamson J K | Methods and compositions for filtration media |
| US20070237901A1 (en) | 2006-03-02 | 2007-10-11 | Moses Timothy C | Water-Stabilized Antimicrobial Organosilane Products, Compositions, and Methods for Using the Same |
| WO2009030640A1 (en) | 2007-09-06 | 2009-03-12 | Vitec Speciality Chemicals Limited | Methods for diluting water-stabilized antimicrobial organosilane compositions |
| US20110293542A1 (en) | 2008-12-25 | 2011-12-01 | Hiroki Nikawa | Antibacterial agent composition and antiviral agent composition comprising silicon-containing compound; antibacterializing method, cleaning/mouth rinsing method; method for fixing antibacterial agent and antiviral agent |
| US20120125226A1 (en) * | 2010-05-07 | 2012-05-24 | Resource Development L.L.C. | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use |
| JP2013071893A (en) | 2011-09-27 | 2013-04-22 | Lixil Corp | Antiviral antibacterial coating agent |
| CN104798809A (en) | 2015-03-12 | 2015-07-29 | 江西领行药业有限公司 | Organosilicon quaternary ammonium long-acting antibacterial product and preparation method thereof |
| WO2016164545A1 (en) | 2015-04-07 | 2016-10-13 | Indusco, Inc. | Antimicrobial articles and compounds therefor |
Non-Patent Citations (1)
| Title |
|---|
| International Search Report & Written Opinion in International Application No. PCT/EP2017/059676, dated Nov. 9, 2017. |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11553714B2 (en) * | 2016-05-03 | 2023-01-17 | Q Surgical Technologies Ltd. | Anti-microbial compositions comprising quaternary organosilane compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017190972A1 (en) | 2017-11-09 |
| US20190141997A1 (en) | 2019-05-16 |
| AU2017259630B2 (en) | 2021-05-13 |
| EP3451832A1 (en) | 2019-03-13 |
| CA3023037A1 (en) | 2017-11-09 |
| US11553714B2 (en) | 2023-01-17 |
| AU2017259630A1 (en) | 2018-11-08 |
| GB201607699D0 (en) | 2016-06-15 |
| US20210204543A1 (en) | 2021-07-08 |
| SG11201809161UA (en) | 2018-11-29 |
| CN109152365A (en) | 2019-01-04 |
| SA518400331B1 (en) | 2022-03-13 |
| ZA201806923B (en) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11553714B2 (en) | Anti-microbial compositions comprising quaternary organosilane compounds | |
| JP6785789B2 (en) | Antimicrobial composition | |
| Fredell | Biological properties and applications of cationic surfactants | |
| CN107072216B (en) | Disinfectant compositions containing quaternary ammonium compounds | |
| CN109169653B (en) | Cation composite disinfectant and application thereof | |
| US8940792B2 (en) | Antimicrobial composition and methods for using same | |
| CN109561694B (en) | Antimicrobial compositions | |
| CN1671831A (en) | Disinfecting composition | |
| KR20110132408A (en) | Bactericidal Compositions Containing Biguanide Compounds | |
| US11944097B2 (en) | Antimicrobial composition | |
| RU2151614C1 (en) | Antibacterial composition and method of sterilization | |
| JP2020183396A (en) | Iodophor composition with improved stability in the presence of organic material | |
| CN106818940A (en) | Disinfectant composition and its application | |
| CN114515255A (en) | Medical and common disinfectant for sterilization and disinfection and disinfectant wet tissue solution | |
| AU2021200502B1 (en) | A Disinfectant | |
| KR20210038465A (en) | Composite for antibacterial and deodorant agent using ionized minerals and persimmon leaf extract and other natural materials | |
| CN111109259A (en) | Composite sterilizing disinfectant | |
| EP2729003A1 (en) | Biocidal composition comprising a biguanide polymer and a tertiary amine oxide | |
| JP2022016360A (en) | Antibacterial/antiviral composition and antibacterial/antiviral fiber product | |
| WO2014060755A1 (en) | Cleaning, sanitizing and sterilizing preparations | |
| US20240172759A1 (en) | Formulation comprising chlorite and percarbonate salts | |
| CN116782907A (en) | Disinfectant | |
| HK40091273A (en) | A disinfectant | |
| KR20230105067A (en) | Disinfectant composition with excellent sterilization power and sterilization rate | |
| WO2012054391A2 (en) | Compositions and methods for reducing microbial levels on a surface |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
| AS | Assignment |
Owner name: Q SURGICAL TECHNOLOGIES LTD, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KEMP, ANDREW;PILLANS, CHARLES MELVILLE;SIGNING DATES FROM 20201218 TO 20201221;REEL/FRAME:054710/0886 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP, ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FEPP | Fee payment procedure |
Free format text: SURCHARGE FOR LATE PAYMENT, LARGE ENTITY (ORIGINAL EVENT CODE: M1554); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |